Independent risk factors for infection in tissue expander breast reconstruction

Plastic and Reconstructive Surgery

Volumn 124, Issue 6, 2009, Pages 1790-1796

  Francis, Stacey H ^b   Ruberg, Robert L ^b   Stevenson, Kurt B ^b   Beck, Catherine E ^b   Ruppert, Amy S ^b   Harper, Justin T ^b   Boehmler, James H ^b   Miller, Michael J ^a  

^a THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ANALYSIS OF VARIANCE; ARTICLE; BREAST RECONSTRUCTION; BREAST TUMOR; COHORT ANALYSIS; COMPARATIVE STUDY; DEVICE REMOVAL; FEMALE; FOLLOW UP; HUMAN; IMPLANT; INCIDENCE; INFECTION; MASTECTOMY; METHODOLOGY; MIDDLE AGED; PATHOLOGY; PHYSIOLOGY; POSTOPERATIVE CARE; PROBABILITY; RETROSPECTIVE STUDY; RISK FACTOR; SURGICAL INFECTION; TIME; TREATMENT OUTCOME; WOUND HEALING;

ADULT; AGED; ANALYSIS OF VARIANCE; BREAST NEOPLASMS; COHORT STUDIES; DEVICE REMOVAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; MAMMAPLASTY; MASTECTOMY; MIDDLE AGED; POSTOPERATIVE CARE; PROBABILITY; PROSTHESIS-RELATED INFECTIONS; RETROSPECTIVE STUDIES; RISK FACTORS; SURGICAL WOUND INFECTION; TIME FACTORS; TISSUE EXPANSION DEVICES; TREATMENT OUTCOME; WOUND HEALING;

EID: 74049086693     PISSN: 00321052     EISSN: None     Source Type: Journal    
DOI: 10.1097/PRS.0b013e3181bf80aa     Document Type: Article

References (28)

1. Cordeiro PG, McCarthy CM. A single surgeon's 12-year experience with tissue expander/implant breast reconstruction: Part I. A prospective analysis of early complications. Plast Reconstr Surg. 2006;118:825-831.
2. Armstrong RW, Berkowitz RL, Bolding F. Infection following breast reconstruction. Ann Plast Surg. 1989;23:284-288.
3. Pinsolle V, Grinfeder C, Mathoulin-Pelissier S, Faucher A. Complications analysis of 266 immediate breast reconstructions. J Plast Reconstr Aesthet Surg. 2006;59:1017-1024.
4. Disa JJ, Ad-El DD, Cohen SM, Cordeiro PG, Hidalgo DA. The premature removal of tissue expanders in breast reconstruction. Plast Reconstr Surg. 1999;104:1662-1665.
5. Krueger EA, Wilkins EG, Strawderman M, et al. Complications and patient satisfaction following expander/implant breast reconstruction with and without radiotherapy. Int J Radiat Oncol Biol Phys. 2001;49:713-721.
6. Nahabedian MY, Tsangaris T, Momen B, Manson P. Infectious complications following breast reconstruction with expanders and implants. Plast Reconstr Surg. 2003;112:467-476.
7. Kirkland KB, Briggs JB, Trivette SL, Wilkinson WE, Sexton J. The impact of surgical-site infections in the 1990s: Attributable mortality, excess length of hospitalization, and extra costs. Infect Control Hosp Epidemiol. 1999;20:725-730.
8. Olsen MA, Chu-Ongsakul S, Brandt K, Dietz JR, Mayfield J, Fraser VJ. Hospital-associated costs due to surgical site infection after breast surgery. Arch Surg. 2008;143:53-60; discussion 61.
9. Handel N, Jensen JJ, Black Q, Waisman JR, Silverstein MJ. The fate of breast implants: A critical analysis of complications and outcomes. Plast Reconstr Surg. 1995;9:1521-1533.
10. Spear S, Majidian A. Immediate breast reconstruction in two stages using textured, integrated-valve tissue expanders and breast implants: A retrospective review of 171 consecutive breast reconstructions from 1989 to 1996. Plast Reconstr Surg. 1998;101:53-63.
11. Kjoller K, Holmich LR, Jacobsen PH, et al. Epidemiologic investigation of local complications after cosmetic breast surgery in Denmark. Ann Plast Surg. 2002;48:229-237.
12. Malavaud S, Reme C, Gangloff D, Roques C, Chavoin JP. Surgical site infection surveillance in breast implants surgery. Ann Chir Plast Esthet. 2005;50:134-137.
13. Cordeiro PG, Pusic AL, Disa JJ, McCormick B, VanZee K. Irradiation after immediate tissue expander/implant breast reconstruction: Outcomes, complications, aesthetic results, and satisfaction among 156 patients. Plast Reconstr Surg. 2004; 113:877-881. (Pubitemid 39195747)
14. Horan T, Andrus M, Dudeck M. CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control 2008;36:309-332.
15. Pittet B, Montandon D, Pittet D. Infection in breast implants. Lancet Infect Dis. 2005;5:94-106.
16. Barnett A, Lavey E, Pearl RM, Vistnes LM. Toxic shock syndrome from an infected breast prosthesis. Ann Plast Surg. 1983;10:408-410.
17. Holm C, Muhlbauer W. Toxic shock syndrome in plastic surgery patients: Case report and review of literature. Aesthetic Plast Surg. 1998;22:180-184.
18. Poblete JV, Rodgers JA, Wolfort FG. Toxic shock syndrome as a complication of breast prosthesis. Plast Reconstr Surg. 1995;96:1702-1708.
19. Giesecke J, Arnander C. Toxic shock syndrome after augmentation mammaplasty. Ann Plast Surg. 1986;17:532-533.
20. Lindsey JK. Models for Repeated Measurements. New York: Oxford University Press; 1993.
21. Hosmer DW Jr, Lemeshow S. Applied Logistic Regression. 2nd ed. New York: Wiley; 2000.
22. SAS Institute. SAS/STAT 1999: SAS/STAT User's Guides, Online Documentation. Cary, NC: SAS Institute; 1999.
23. Kao JT, Dagun AB, Mahoney J, et al. The histopathological changes in irradiated vs nonradiated tissue-expanded skin in the porcine model. Ann Plast Surg. 1997;39:287-291.
24. Hopewell JW, Calvo W, Jaenke R, et al. Microvasculature and radiation damage. Recent Results Cancer Res. 1993;130: 1-16.
25. Burkhardt BR, Fried M, Schnur PL, Tofield JJ. Capsules, infection, and intraluminal antibiotics. Plast Reconstr Surg. 1981;68:43-49.
26. Fredman AM, Jackson IT. Infections in breast implants. Infect Dis Clin North Am. 1989;3:275-287.
27. Darouiche RO. Treatment of infections associated with surgical implants. N Engl J Med. 2004;350:1422-1429.
28. Haley RW, Culver DW, White JW, et al. The efficacy of infection surveillance and control programs in preventing nosocomial infections in US hospitals. Am J Epidemiol. 1985; 121:182-205.